Knee pain relief: which PRP injection works best?
NCT ID NCT04807270
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different ways of preparing Platelet-Rich Plasma (PRP) injections for people with knee osteoarthritis. 96 participants received three injections over six weeks and were followed for six months. The goal was to see which method better reduces pain, improves function, and enhances quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Platelet-Rich Plasma (PRP) injection
- What this could lead to
- If successful, this could show which PRP preparation method works better for easing knee pain and improving mobility in osteoarthritis.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not apply widely. PRP is a common treatment but its effectiveness is still debated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
96 people
The number who actually took part.
- Started
-
May 2021
- Finished
-
Jan 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with chronic symptomatic knee pain between the ages of 30 and 75 years * Presence of Kellgren-Lawrence stage 2-3 osteoarthritis on current anterior-posterior knee radiographs * The ability to walk independently Exclusion Criteria: * Previous treatment with an autologous blood product or stem cell preparation * Severe knee effusion * Concomitant severe meniscus or ligament injury * Recent cancer or other tumors * History of knee surgery * Previous diagnosis of a neuromuscular, infectious, or inflammatory disease * Bleeding disorders and/or use of warfarin * Body mass index above 40 kg/m² * Cardiac or systemic diseases that could affect participation in the exercise program
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Istanbul, Fatıh, 34034, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight
- Can shockwave plus injections quiet knee arthritis pain?